Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 86C89EA0-31DE-11E7-B279-94B2AD28A064 or (type any "bookEditor issueEditor" and edito... cql: keyword exact "therapy"

Add to list
- Journal Article
- A1
- open access
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor Verghote (UGent) , Lindsay Poppe (UGent) , Sofie Verbeke (UGent) , Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost (UGent) , Geert Villeirs (UGent) , Pieter De Visschere (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
- Journal Article
- A1
- open access
The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry

Nicolaas Lumen (UGent) , Elise De Bleser, Sarah Buelens (UGent) , Wesley Verla, Filip Poelaert, Wietse Claeys (UGent) , Valerie Fonteyne (UGent) , Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Kathia De Man (UGent) , et al.

(2021) EUROPEAN UROLOGY OPEN SCIENCE. 29. p.68-76
Add to list
Routine histopathological examination after female-to-male gender-confirming mastectomy

Sofie Van Renterghem, Jo Van Dorpe (UGent) , Stan Monstrey (UGent) , Justine Defreyne (UGent) , Karel Claes (UGent) , Marleen Praet, Sofie Verbeke (UGent) , Guy T'Sjoen (UGent) and Mieke Van Bockstal (UGent)

(2018) BRITISH JOURNAL OF SURGERY. 105(7). p.885-892
Add to list
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

Sarah Buelens (UGent) , Filip Poelaert, Bert Dhondt (UGent) , Valerie Fonteyne (UGent) , Pieter De Visschere (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , Geert Villeirs (UGent) , Kathia De Man (UGent) , Sylvie Rottey (UGent) , et al.

(2018) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 36(4). p.158.e13-158.e20
Add to list
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora Sundahl, Katrien De Wolf, Sylvie Rottey (UGent) , Karel Decaestecker (UGent) , Daan De Maeseneer (UGent) , Annabel Meireson (UGent) , Els Goetghebeur (UGent) , Valerie Fonteyne (UGent) , Sofie Verbeke (UGent) , Pieter De Visschere (UGent) , et al.

(2017) JOURNAL OF TRANSLATIONAL MEDICINE. 15.

Academic Bibliography

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry

Routine histopathological examination after female-to-male gender-confirming mastectomy

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Contents

Support

Contact